STONEGATE SYSTEMSShort version: there is no single best payment processor for peptides. The best setup is a high-risk primary, a pre-underwritten backup, and a non-card fallback - because every rail on this page fails eventually, and the stores that survive are the ones that planned for it.
Why every ranking you've read is a sales page
Search "best payment processor for peptides" and the top results are written by high-risk payment brokers. Their business model is a residual - a cut of every transaction you process, forever - so their "comparison" always concludes that you should fill out their form. None of them will tell you the two things that actually decide your outcome: that peptides sit in a category card networks treat as restricted, and that the site itself, not the application, is what underwriting reads.
We have no residual to protect. Stonegate builds and monitors research-use-only peptide storefronts - the store is the product, the processing is your relationship. That's the only reason this page can say plainly which rails fail, how often, and what it costs when they do.
The scoring criteria
Five numbers matter. Everything else - dashboards, "dedicated account managers", integrations - is decoration.
- Shutdown risk. Probability the rail terminates you in year one. This dwarfs fees. A processor charging 2.9% that shuts you down at month four is infinitely more expensive than one charging 5% that doesn't.
- Real fees. The all-in rate after gateway fees, monthly minimums, and per-transaction charges - not the teaser rate on the pricing page.
- Reserves. High-risk merchant accounts commonly hold a 5-10% rolling reserve for 90-180 days. On $50k/month that's up to $30k of your cash sitting in someone else's account.
- Approval time. Mainstream rails approve in minutes and terminate later. Real high-risk underwriting takes 1-3 weeks and holds.
- Volume ceilings. New high-risk accounts often cap monthly volume (commonly $25k-$50k) for the first 3-6 months. A viral month can breach the cap and freeze funds.
Card high-risk processors, compared honestly
First, clear the field: Stripe, Square, PayPal, and Shopify Payments are not options. All four prohibit peptide sales in their acceptable-use terms, and all four terminate with funds held 90-180 days when their classifiers catch you - usually after you've built real volume, because that's when the risk review triggers. If you're reading this after the email, start with what to do when Stripe shuts down your peptide store; the recovery playbook is the same for all four.
That leaves genuine high-risk acquirers - the processors built for categories Visa's Integrity Risk Program (VIRP, which replaced the old brand-protection program in 2023) flags for enhanced monitoring. Names you'll encounter: PaymentCloud, Easy Pay Direct, Durango Merchant Services, PayKings, Soar Payments, and a rotating cast of ISOs reselling the same few back-end acquirers. Honest read:
| Factor | Mainstream (Stripe etc.) | High-risk card | ACH / eCheck | Crypto | P2P (Zelle etc.) |
|---|---|---|---|---|---|
| Shutdown risk, yr 1 | Near-certain | Moderate | Low-moderate | Low | High per-account |
| All-in rate | 2.9% + 30¢ | 3.5-6%+ | ~1-2% | ~1% or self-host free | 0% |
| Rolling reserve | On termination | 5-10% / 90-180d | Rare | None | None |
| Approval | Minutes (then revoked) | 1-3 weeks | Days-2 weeks | Instant-days | Instant |
| Volume ceiling | n/a | $25k-$50k/mo early | Negotiable | None | $500-$5k/wk |
Three things the brokers won't say out loud:
- The quoted rate is a floor. "From 2.95%" becomes 4.5-6% once the underwriter sees the word peptide. Budget 5% all-in and be pleasantly surprised.
- Approval is underwriting your website, not your paperwork. The underwriter reads your product pages the same way the FDA does - looking for human-use signals. Research-use framing, no dosing content, visible disclaimers, a real refund policy, and matching legal entity details decide the file. The full underwriting checklist is in our peptide merchant account guide.
- Approval is not permanence. High-risk acquirers get squeezed by their sponsor banks too. Accounts that sailed through underwriting in January get "portfolio review" letters in June. And a for-cause termination can put you on the MATCH list - Mastercard's shared blacklist that follows you to every future application for five years. What that means in practice is covered in our MATCH list guide.
Keep a 1.5% chargeback ratio as your hard internal cap - the networks' excessive-chargeback programs trigger below their published thresholds in practice, and chargebacks are the number-one stated cause on termination letters.
ACH and eCheck - slower, cheaper, sturdier
ACH is the quiet workhorse of peptide payments. Bank-to-bank transfer, typically ~1% or a flat $1-$3 per transaction, no card networks involved - which means no VIRP, no MATCH list, no interchange politics. Settlement runs 1-3 business days, and disputes exist (ACH returns) but run far below card chargeback rates because the buyer has to call their bank rather than tap a button.
The trade-offs are real: checkout friction is higher (customers type routing and account numbers or link a bank), conversion drops a few points against card, and ACH originators can still offboard you - it's lower-drama than card, not immune. But as a second rail it is the single best stability-per-dollar purchase available to a peptide store. Several processors bundle eCheck with a high-risk card account; take it even if you don't plan to promote it.
Crypto settlement: where it fits and where it fails
Crypto is the only rail nobody can terminate. A self-hosted BTCPay Server instance costs $0 in processing fees, settles to a wallet you control, and has no acceptable-use policy. Hosted options (Coinbase Commerce and similar, around 1%) are easier to run but reintroduce a counterparty with terms of service - some have offboarded research-chemical merchants, so read the policy before you build on one.
Where it fails: conversion. In our experience across dozens of stores, crypto carries a low single-digit share of checkout when it's one option among several - most research buyers reach for a card or bank transfer first. Stores that went crypto-only after a card shutdown typically watch revenue fall 60-80% versus their card baseline. Crypto is your unkillable floor, not your business model. Run it from day one so the option exists the morning something else dies.
P2P rails as a bridge, never a foundation
Zelle, Venmo, and Cash App show up in every peptide operator group chat because they're free and instant. They are also personal-payment networks whose terms prohibit commercial use of personal accounts, with per-account limits around $500-$5k a week and freeze behavior that offers no merchant protections and no appeal worth the name. Fine as a manual bridge for your first handful of orders or as an emergency fallback while a real rail underwrites - reckless as the foundation of a store doing real volume. The full risk breakdown is in Zelle, Venmo, and Cash App for a peptide business.
The real answer: primary + pre-configured backup + non-card fallback
Here is the architecture every peptide store that survives past year one converges on:
- Primary: a genuine high-risk card merchant account, underwritten against a compliant site. Takes the bulk of volume at 3.5-6%.
- Backup: a second card account with a different acquiring bank, opened while you don't need it, kept warm with a trickle of transactions. Underwriting takes 1-3 weeks; you cannot start it the day your primary dies.
- Fallback: ACH and crypto live at checkout from day one, so a card outage degrades revenue instead of zeroing it.
This isn't paranoia, it's base rates. The FDA sent warning letters to seven peptide vendors on a single day, March 31, 2026, and processors read those letters too - enforcement waves at the FDA reliably become termination waves at the acquirers a few weeks later. The rules keep moving; your payment stack has to assume it. The deeper mechanics - descriptors, gateways, orchestrating multiple rails - live in our peptide payment processing guide.
And before any of it: the site has to survive the underwriting read. If your product pages carry human-use language, an underwriter declines you and a processor that already approved you terminates you. The free 60-second audit reads your storefront the way an underwriter does and tells you what would fail - before you burn an application on it.
Hot-swapping rails without rebuilding your store
The overlooked variable in processor selection isn't the processor - it's your store's architecture. On most platforms, the payment integration is welded into the theme and checkout: swapping processors means developer time, checkout rewrites, and days of downtime while orders bounce. That's how a 48-hour processor problem becomes a three-week revenue hole.
Build it the other way: payment rails as configuration, not construction. Every store we ship treats each rail - card gateway, ACH, crypto, manual - as a config entry that can be enabled, disabled, or replaced without touching storefront code. When a processor sends the termination email at 9 a.m., the backup is live before lunch. That single design decision is worth more than any processor on this page, because it converts a fatal event into an annoying one.
Questions, answered straight
So which processor should I actually apply to first?
A high-risk specialist that will name its acquiring bank and put your rate and reserve terms in writing before you sign - PaymentCloud, Easy Pay Direct, and Durango are the usual starting shortlist. But the honest answer is: fix your site first. The same application gets approved or declined based on what your product pages say, so the order of operations is compliant site, then application, then a second application at a different bank.
Can I just use Stripe until I get caught?
You can, and the ending is always the same: termination with 90-180 days of funds held, right when volume gets meaningful - their reviews trigger on growth. You'll also have trained your customers on a checkout that vanishes overnight. It's not a strategy, it's a countdown.
What will a peptide merchant account really cost me?
Budget 4-6% all-in, a $25-$50 monthly gateway/account fee, and a 5-10% rolling reserve released on a 90-180 day cycle. If someone quotes materially better than that for a peptide store, ask which acquiring bank - and whether they've told the bank what you sell.
Is crypto-only viable?
Viable to exist, not to grow. Stores forced onto crypto-only typically lose well over half their revenue versus card. Run crypto as the unkillable fallback in a three-rail stack, not as the whole stack.
Does Stonegate get me a merchant account?
No - and that's deliberate. We don't broker processing or take residuals, which is why this comparison can be honest. What we build is the thing underwriters approve: a compliant storefront with rails as config, so approvals come easier and swaps don't require a rebuild. Risk reduction, not guarantees - nobody honest can guarantee a processor outcome.
This is general information for store operators, not legal or financial advice. Payment terms, network rules, and enforcement posture change - verify current terms with any processor before you sign.